- Lead the global TAVR market development team within Structural Heart - Strategy focused on indication and geo expansion, therapy awareness, health equity, economic value, valve program capacity and throughput, and lifetime management of valve patients-Co-chair of Cardiovascular (CV) Market Development Coalition, drive talent development and synergies across CV business lanes by discussing market development frameworks, best practices, non-invasive cardiology strategies, and health equity initiatives, enabling learning, reproducibility, and scalability across the organization#Engineeringtheextraordinary

-Lead the 8-member Cardiovascular Diagnostics and Services Market Development team that is increasing market penetration across all 4 market indications and achieved high team organizational health scores of 94% for engagement, 86% for innovation, and 83% for inclusion-Strategy focuses on the key pillars of awareness & education, advocacy, referral network development, and evidence dissemination -Co-chair of Cardiovascular (CV) Market Development Coalition, drive talent development and synergies across CV business lanes by discussing market development frameworks, best practices, non-invasive cardiology strategies, and health equity initiatives, enabling learning, reproducibility, and scalability across the organization

-Within 2 years, grew market 12% while increasing market penetration by 5%, leading team of Market Development Managers responsible for increasing patient access and market penetration for the LINQ family of ICMs. -Achieved several growth targets by focusing on customer education and patient pathway development strategies, realizing $45M in incremental revenue growth through market penetration increases for target markets of stroke and AF management (5% penetration growth in stroke and 3% in AF management for $530M US business); 100% to adjusted COVID AOP-As part of Medtronic’s overall COVID recovery strategy, served as cross-business lead for the AHA “Don’t Die of Doubt” public health partnership to alleviate patient fear and get patients’ back to seeking care during the pandemic-Founding member of the pan CV Market Development Coalition to educate/highlight the value of market development and elevates the function within marketing expertise, resulting in a FY21 Cardiovascular Star of Excellence award Graduate of IGNITE high potential leadership develop program

-Managed a 3-person team and oversaw all aspects of stroke indication marketing (strategic direction, market development, commercialization), growing the indication of the LINQ business to over 20%+ of the implants and achieved a market penetration of >20% within a 4+ year timeframe-Spearheaded Neurovascular cross-sell and joint marketing strategies for stroke promotion, achieving the corporate FY18 Star of Excellence award due to these efforts-Led a multi-disciplinary pathway development effort with customers and sales force, enabling better systems of care for stroke patients across the globe and driving patient access to our technology

-Led cryptogenic stroke market development strategy and plan for market expansion of Reveal LINQ-Established the need for insertable cardiac monitors within the cryptogenic stroke patient population by carrying out early market penetration efforts including society engagements, market research, key opinion leader strategy, education initiatives, and market development activities with referral physicians

-Drove customer education for Diagnostics enabling the fastest growing business in Medtronic from FY14 to FY15 with US revenue going from $178M to $458M -Created and implemented a new customer education strategy which included customer training, speaker development, and executing a highly successful Reveal LINQ launch

Marketing Manager, Structural Heart, Medtronic Cardiovascular.Formed an infrastructure and framework for a cross-therapy Structural Heart MICS (minimally invasive) customer experience and led a cross-therapy team on the tactical execution of this multi-therapy/product customer experience; led both upstream and downstream marketing for the beating heart CABG product line

Strategic development of new product platforms in the asepsis, immobilization, and patient assessment markets. Responsible for market analysis for new product opportunities. Developed business case and marketing launch plans for new products in the aforementioned markets.

Roles held: Marketing Leadership Development Rotation, Marketing Manager, Professional Sales Representative, Sales Trainer